1. Home
  2. TARS vs WB Comparison

TARS vs WB Comparison

Compare TARS & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • WB
  • Stock Information
  • Founded
  • TARS 2016
  • WB 2009
  • Country
  • TARS United States
  • WB China
  • Employees
  • TARS N/A
  • WB N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • WB Computer Software: Programming Data Processing
  • Sector
  • TARS Health Care
  • WB Technology
  • Exchange
  • TARS Nasdaq
  • WB Nasdaq
  • Market Cap
  • TARS 2.8B
  • WB 2.8B
  • IPO Year
  • TARS 2020
  • WB 2014
  • Fundamental
  • Price
  • TARS $67.56
  • WB $11.28
  • Analyst Decision
  • TARS Strong Buy
  • WB Buy
  • Analyst Count
  • TARS 7
  • WB 2
  • Target Price
  • TARS $69.43
  • WB $14.00
  • AVG Volume (30 Days)
  • TARS 613.1K
  • WB 961.8K
  • Earning Date
  • TARS 11-04-2025
  • WB 11-18-2025
  • Dividend Yield
  • TARS N/A
  • WB 14.54%
  • EPS Growth
  • TARS N/A
  • WB 9.65
  • EPS
  • TARS N/A
  • WB 1.41
  • Revenue
  • TARS $295,521,000.00
  • WB $1,762,960,000.00
  • Revenue This Year
  • TARS $139.46
  • WB $1.33
  • Revenue Next Year
  • TARS $49.91
  • WB $2.14
  • P/E Ratio
  • TARS N/A
  • WB $8.15
  • Revenue Growth
  • TARS 254.45
  • WB 1.37
  • 52 Week Low
  • TARS $38.51
  • WB $7.10
  • 52 Week High
  • TARS $76.81
  • WB $12.96
  • Technical
  • Relative Strength Index (RSI)
  • TARS 54.32
  • WB 42.93
  • Support Level
  • TARS $65.30
  • WB $11.12
  • Resistance Level
  • TARS $74.83
  • WB $11.61
  • Average True Range (ATR)
  • TARS 2.87
  • WB 0.36
  • MACD
  • TARS -0.99
  • WB -0.04
  • Stochastic Oscillator
  • TARS 19.64
  • WB 19.02

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About WB Weibo Corporation

Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.

Share on Social Networks: